A mutation in the human immunodeficiency virus type 1 gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41

被引:53
作者
Davis, MR
Jiang, JY
Zhou, J
Freed, EO
Aiken, C
机构
[1] Vanderbilt Univ, Dept Microbiol & Immunol, Sch Med, Nashville, TN 37232 USA
[2] NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, Frederick, MD 21702 USA
关键词
D O I
10.1128/JVI.80.5.2405-2417.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Gag protein of human immunodeficiency virus type I (HIV-1) associates with the envelope protein complex during virus assembly. The available evidence indicates that this interaction involves recognition of the gp41 cytoplasmic tail (CT) by the matrix protein (MA) region of Pr55(Gag). Here we show that substitution of Asp for Leu at position 49 (L49D) in MA results in a specific reduction in particle-associated gp120 without affecting the levels of gp41. Mutant virions were markedly reduced in single-cycle infectivity despite a relatively modest defect in fusion with target cells. Studies with HIV-1 particles containing decreased levels of envelope proteins suggested that the L49D mutation also inhibits a postentry step in infection. Truncation of the gp41 tail, or pseudotyping by vesicular stomatitis virus glycoprotein, restored both the fusion and infectivity of L49D mutant virions to wild-type levels. Truncation of gp41 also resulted in equivalent levels of gp120 on particles with and without the MA mutation and enhanced the replication of the L49D mutant virus in T cells. The impaired fusion and infectivity of L49D mutant particles were also complemented by a single point mutation in the gp41 CT that disrupted the tyrosine-containing endocytic motif. Our results suggest that an altered interaction between the MA domain of Gag and the gp41 cytoplasmic tail leads to dissociation of gp120 from gp41 during HTV-1 particle assembly, thus resulting in impaired fusion and infectivity.
引用
收藏
页码:2405 / 2417
页数:13
相关论文
共 88 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[3]   NEF STIMULATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL DNA-SYNTHESIS [J].
AIKEN, C ;
TRONO, D .
JOURNAL OF VIROLOGY, 1995, 69 (08) :5048-5056
[4]   Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions [J].
Akari, H ;
Fukumori, T ;
Adachi, A .
JOURNAL OF VIROLOGY, 2000, 74 (10) :4891-4893
[5]  
ANDREASSEN H, 1990, J ACQ IMMUN DEF SYND, V3, P615
[6]   A NUCLEAR-LOCALIZATION SIGNAL WITHIN HIV-1 MATRIX PROTEIN THAT GOVERNS INFECTION OF NONDIVIDING CELLS [J].
BUKRINSKY, MI ;
HAGGERTY, S ;
DEMPSEY, MP ;
SHAROVA, N ;
ADZHUBEI, A ;
SPITZ, L ;
LEWIS, P ;
GOLDFARB, D ;
EMERMAN, M ;
STEVENSON, M .
NATURE, 1993, 365 (6447) :666-669
[7]   Pleiotropic mutations in the HIV-1 matrix protein that affect diverse steps in replication [J].
Casella, CR ;
Raffini, LJ ;
Panganiban, AT .
VIROLOGY, 1997, 228 (02) :294-306
[8]   A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes [J].
Cavrois, M ;
de Noronha, C ;
Greene, WC .
NATURE BIOTECHNOLOGY, 2002, 20 (11) :1151-1154
[9]   HIV-1 REVERSE TRANSCRIPTION - A TERMINATION STEP AT THE CENTER OF THE GENOME [J].
CHARNEAU, P ;
MIRAMBEAU, G ;
ROUX, P ;
PAULOUS, S ;
BUC, H ;
CLAVEL, F .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 241 (05) :651-662
[10]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752